Indicators of treatment responsiveness to rituximab and plasmapheresis in antibody-mediated rejection after kidney transplantation.

Immenschuh, Stephan

Indicators of treatment responsiveness to rituximab and plasmapheresis in antibody-mediated rejection after kidney transplantation. [electronic resource] - Transplantation Jan 2015 - 56-62 p. digital

Publication Type: Journal Article; Research Support, Non-U.S. Gov't

1534-6080

10.1097/TP.0000000000000244 doi


Antibodies, Monoclonal, Murine-Derived--adverse effects
Biomarkers--blood
Biopsy
Graft Rejection--blood
HLA Antigens--immunology
Humans
Immunosuppressive Agents--adverse effects
Isoantibodies--blood
Kidney Transplantation--adverse effects
Patient Selection
Plasmapheresis--adverse effects
Predictive Value of Tests
Proteinuria--blood
Retrospective Studies
Risk Factors
Rituximab
Time Factors
Treatment Outcome